SCIENTIFIC REPORT 2004 - Sylvester Comprehensive Cancer Center

More documents

Recommendations

Info

P U B L I C A T I O N S 2 0 0 2 - 2 0 0 3 McGregor, BA, Antoni, MH, Boyers, A, Alferi, SM, Blomberg, BB , and Carver, CS. Cognitive behavioral stress management increases benefit finding and immune function among women with early stage breast cancer. Journal of Psychosomatic Research 54:1-8, 2003. Tanguy, Le Gac N and Boehmer, PE. Activation of the herpes simplex virus type-1 origin-binding protein (UL9) by heat shock proteins. Journal of Biological Chemistry 277:5660-6, 2002. Nimonkar, AV and Boehmer, PE. In vitro strand exchange promoted by the herpes simplex virus type-1 single strand DNA-binding protein (ICP8) and DNA helicase-primase. Journal of Biological Chemistry 277:15182-9, 2002. Villani, G, Tanguy Le Gac, N, Wasungu, L, Burnouf, D, Fuchs, RP, and Boehmer, PE. Effect of manganese on in vitro replication of damaged DNA catalyzed by the herpes simplex virus type- 1 DNA polymerase. Nucleic Acids Research 30:3323-32, 2002. Boehmer, PE and Nimonkar, AV. Herpes virus replication. IUBMB Life 55:13-22, 2003. Nimonkar, AV and Boehmer PE. The herpes simplex virus type-1 single-strand DNA-binding protein (ICP8) promotes strand invasion. Journal of Biological Chemistry 278:9678-82, 2003. Nimonkar, AV and Boehmer, PE. On the mechanism of strand assimilation by the herpes simplex virus type-1 single-strand DNA-binding protein (ICP8). Nucleic Acids Research 31:5275-81, 2003. Nimonkar, AV and Boehmer PE. Reconstitution of recombination-dependent DNA synthesis in herpes simplex virus 1. Proceedings of the National Academy of Sciences USA 100:10201-6, 2003. Boehmer, PE and Villani, G. Herpes simplex virus type-1: a model for genome transactions. Progress in Nucleic Acid Research and Molecular Biology 75:139-171, 2003. Anderson, KC, Boise, LH, Louie, R, and Waxman, S. Arsenic trioxide in multiple myeloma: rationale and future directions. Cancer Journal 8:12- 25, 2002. Bahlis, NJ, McCafferty-Grad, J, Jordan-McMurry, I, Neil, J, Reis, I, Kharfan-Dabaja, M, Eckman, J, Goodman, M, Fernandez, HF, Boise, LH, and Lee, KP. Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma. Clinical Cancer Research 8:3658-68, 2002. Ghosh, SK, Wood, C, Boise, LH, Mian, AM, Deyev, VV, Feuer, G, Toomey, NL, Shank, NC, Cabral, L, Barber, GN, and Harrington, WJ, Jr. Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidinemediated inhibition of NF-kappa B. Blood 101:2321-7, 2003. McCafferty Grad, J, Bahlis, N, Aguilar, T, Kratt, N, Lee, KP, and Boise, LH. Arsenic trioxide utilizes caspase dependent and caspase independent death pathways in multiple myeloma cells. Molecular Cancer Therapeutics 2:1155-64, 2003. Beaupre, DM, McCafferty Grad, J, Bahlis, NJ, Boise, LH, and Lichtenheld, MG. Farnesyl transferase inhibitors sensitize to death receptor signals and induce apoptosis in multiple myeloma cells. Leukemia & Lymphoma 44:2123-34, 2003. Yang, ES, Maiorino, CA, Roos, BA, Knight, SR, and Burnstein, KL . Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer. Molecular and Cellular Endocrinology 186:69-79, 2002. Whitlatch, LW, Young, MV, Schwartz, GG, Flanagan, JN, Burnstein, KL , Lokeshwar, BL, Rich, ES, Holick, MF, and Chen, TC. 25- Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. Journal of Steroid Biochemistry and Molecular Biology 81:135-40, 2002. UM/Sylvester Comprehensive Cancer Center Scientific Report 2004 159
P U B L I C A T I O N S 2 0 0 2 - 2 0 0 3 Kizu, R, Okamura, K, Toriba, A, Kakishima, H, Mizokami, A, Burnstein, KL , and Hayakawa, K. A role of aryl hydrocarbon receptor in the antiandrogenic effects of polycyclic aromatic hydrocarbons in LNCaP human prostate carcinoma cells. Archives of Toxicology 77:335-43, 2003. Yang, E and Burnstein, KL . Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. Journal of Biological Chemistry 278:46862-68, 2003. Chen, TC, Holick, MF, Lokeshwar, BL, Burnstein, KL , and Schwartz, GG. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer. Recent Results in Cancer Research 164:273-88, 2003. Kizu, R, Okamura, K, Toriba, A, Mizokami, A, Burnstein, KL , Klinge, CM, and Hayakawa, K. Antiandrogenic activities of diesel exhaust particle extracts in PC3/AR human prostate carcinoma cells. Toxicological Science 76:299-309, 2003. Carraway, KL , Perez, A, Idris, N, Jepson, S, Arango, M, Komatsu, M, Haq, B, Price-Schiavi, SA, Zhang, J, and Carraway, CA. Muc4/ sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. Progress in Nucleic Acid Research and Molecular Biology 71:149-85, 2002. Swan, JS, Arango, ME, Carothers Carraway, CA, and Carraway, KL . An ErbB2-Muc4 complex in rat ocular surface epithelia. Current Eye Research 24:397-402, 2002. Jepson, S, Komatsu, M, Haq, B, Arango, ME, Huang, D, Carraway, CA, and Carraway, KL . Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinase. Oncogene 21:7524-32, 2002. Komatsu, M, Arango, ME, and Carraway, KL . Synthesis and secretion of Muc4/sialomucin complex: implication of intracellular proteolysis. Biochemical Journal 368:41-48, 2002. 160 Ramsauer, VP, Carothers Carraway, CA, Salas, PJ, and Carraway, KL . Muc4/Sialomucin complex, the intramembrane ErbB2 ligand, translocates ErbB2 to the apical surface in polarized Epithelial cells. Journal of Biological Chemistry 278:30142- 47, 2003. Carraway, KL , Ramsauer, VP, Haq, B, and Carothers Carraway, CA. Cell signaling through membrane mucins. BioEssays 25:66-71, 2003. Fischer, BM, Cuellar, JG, Diehl, ML, deFreytas, AM, Zhang, J, Carraway, KL , and Voynow, JA. Neutrophil elastase increases MUC4 expression in normal human bronchial epithelial cells. American Journal of Physiology-Lung Cellular Molecular Physiology 284:L671-79, 2003. Hu, YP, Haq, B, Carraway, KL , Savaraj, N, and Lampidis, TJ. Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells. Pharmacology, Biochemistry, and Behavior 65:1419-25, 2003. Soto, P, Price-Schiavi, SA, and Carraway, KL . SMAD2 and SMAD7 Involvement in the posttranslational regulation of Muc4 via the transforming growth factor-beta and interferongamma pathways in rat mammary epithelial cells. Journal of Biological Chemistry 278:20338-44, 2003. Perez, A, Barco, R, Fernandez, I, Price-Schiavi, SA, and Carraway, KL . PEA3 transactivates the Muc4/Sialomucin Complex promoter in mammary epithelial and tumor cells. Journal of Biological Chemistry 278(38):36942-52, 2003. Perczek, RE, Burke, MA, Carver, CS, Krongrad, A, and Terris, MK. Facing a prostate cancer diagnosis: who is at risk for increased distress? Cancer 94:2923-29, 2002. Culver, JL, Arena, PL, Antoni, MH, and Carver, CS. Coping and distress among women under treatment for early stage breast cancer: Comparing African Americans, Hispanics, and non-Hispanic Whites. Psycho-oncology 11:495-504, 2002. UM/Sylvester Comprehensive Cancer Center Scientific Report 2004
Page 1 and 2:
S C I E N T I F I C R E P O R T 2 0
Page 3 and 4:
I N T R O D U C T I O N A N D P R O
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
L E A D E R S H I P MULTIDISCIPLINA
Page 13 and 14:
L E A D E R S H I P EXTERNAL ADVISO
Page 15 and 16:
C A N C E R P R E V E N T I O N A N
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
C L I N I C A L O N C O L O G Y R E
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
T U M O R C E L L B I O L O G Y P R
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
T U M O R I M M U N O L O G Y P R O
Page 119 and 120:
T U M O R I M M U N O L O G Y P R O
Page 121 and 122: T U M O R I M M U N O L O G Y P R O
Page 143 and 144: V I R A L O N C O L O G Y P R O G R
Page 157 and 158: S H A R E D R E S O U R C E S 3) La
Page 159 and 160: S H A R E D R E S O U R C E S C E L
Page 161 and 162: S H A R E D R E S O U R C E S D N A
Page 163 and 164: S H A R E D R E S O U R C E S G E N
Page 165 and 166: S H A R E D R E S O U R C E S I N F
Page 167 and 168: S H A R E D R E S O U R C E S P O P
Page 169 and 170: P U B L I C A T I O N S 2 0 0 2 - 2
Page 171: P U B L I C A T I O N S 2 0 0 2 - 2
Page 205 and 206: G L O S S A R Y IFN—interferon IL
show all

SCIENTIFIC REPORT 2004 - Sylvester Comprehensive Cancer Center

Create successful ePaper yourself

Delete template?

Save as template?